E84
Conditions
Interventions
Group 1: Patients with cystic fibrosis and healthy participants receive digital nocturnal cough monitoring using a smartphone app. This will be used to investigate the natural course of cough under st
Sponsors
Charité - Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of Cystic Fibrosis Availability of a smartphone
Exclusion criteria
Exclusion criteria: Comorbid condition likely to affect the patients cough frequency (e.g. post lung transplantation) or ability to adhere to monitoring. The regular presence of a person of the same sex during nocturnal cough monitoring is also an exclusion criterion, as this may influence cough monitoring.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nocturnal cough in CF patients receiving standard of care CF treatment and healthy controls | — |
Secondary
| Measure | Time frame |
|---|---|
| relationship between nocturnal cough frequency and CF lung disease severity measured by FEV1pp relationship between nocturnal cough frequency and pulmonary exacerbation according identification of individual thresholds at which normal variability is exceeded and incipient lung deterioration can be assumed allowing for an alert system | — |
Countries
France, Germany, Ireland
Contacts
Public ContactMarcus Mall
Charité- Universitätsmedizin Berlin
Outcome results
None listed